Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome easlfibronostg on June 26, 2026 Category: Publication Highlights, Publications Tag: Diabetes, Hep B, Identification, LIVERFASt Post navigation Previous: Previous post: LIVERFASt Demonstrates the Feasibility of a Screening Program for MASLDNext: Next post: Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cure
